Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus (Q39653094)

13 September 2017

title

Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus (English)

1 reference

13 September 2017

Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus (English)

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

17 July 2024

1 reference

1 reference

1 reference

6

Roberto Cattaneo

1 reference

13 September 2017

10

Christian J. Buchholz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858718

17 July 2024

author name string

Thomas Schaser

2

1 reference

13 September 2017

Martina Zimmermann

3

1 reference

13 September 2017

Sorin Armeanu

4

1 reference

13 September 2017

Michael Bitzer

7

1 reference

13 September 2017

Klaus Cichutek

9

1 reference

13 September 2017

Michael D. Mühlebach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858718

17 July 2024

Kay-Martin O. Hanschmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858718

17 July 2024

Ulrich M. Lauer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858718

17 July 2024

language of work or name

English

0 references

publication date

21 September 2010

1 reference

full work available at URL

13 September 2017

https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Liver_Cancer_Protease_Activity_Profiles_Support_Therapeutic_Options_with_Matrix_Metalloproteinase_Activatable_Oncolytic_Measles_Virus/22384532/1/files/39829955.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858718

http://cancerres.aacrjournals.org/cgi/content/abstract/70/19/7620

17 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858718

https://aacrjournals.org/cancerres/article-pdf/70/19/7620/2642110/7620.pdf

17 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

17 July 2024

1 reference

13 September 2017

volume

70

1 reference

13 September 2017

issue

19

1 reference

13 September 2017

page(s)

7620-7629

1 reference

Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis.

17 July 2024

2

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

17 July 2024

3

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

17 July 2024

4

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.

17 July 2024

5

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

17 July 2024

6

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

17 July 2024

7

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed

17 July 2024

8

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model

17 July 2024

9

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells

17 July 2024

10

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases

17 July 2024

11

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.

17 July 2024

12

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Matrix metalloproteinases and tumor metastasis

17 July 2024

13

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

The urokinase plasminogen activator system: a target for anti-cancer therapy.

17 July 2024

15

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis

17 July 2024

16

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers

17 July 2024

17

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas

17 July 2024

18

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis

17 July 2024

19

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma

17 July 2024

20

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

17 July 2024

21

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region

17 July 2024

22

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

17 July 2024

Q106873906

24

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses

17 July 2024

25

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers

17 July 2024

26

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Affinity thresholds for membrane fusion triggering by viral glycoproteins

17 July 2024

28

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Measles virus spread and pathogenesis in genetically modified mice

17 July 2024

29

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice

17 July 2024

30

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.

17 July 2024

32

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

A matrix metalloproteinase expressed on the surface of invasive tumour cells

17 July 2024

33

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix

17 July 2024

34

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Matrix metalloproteinases, the pros and cons, in liver fibrosis

17 July 2024

35

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9

17 July 2024

36

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

17 July 2024

37

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases

17 July 2024

38

1 reference

https://api.crossref.org/works/10.1158/0008-5472.CAN-09-4650

17 July 2024

Identifiers

1 reference

13 September 2017

1 reference